#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicle centre lymphoma follicular grade I, II – III Synovial sarcoma recurrent Liver transplant rejection Epilepsy with myoclonic-atonic seizures Plasma cell myeloma recurrent CDKL5 deficiency disorder Transitional cell cancer of the renal pelvis and ureter Anal cancer recurrent Biotinidase deficiency Chronic inflammatory demyelinating polyradiculoneuropathy Ductal adenocarcinoma of pancreas Pleomorphic liposarcoma Infertility female Acute graft versus host disease in liver Post transplant lymphoproliferative disorder More trials…

    Learn about Rare Diseases

    Castleman’s disease – Treatment Mucopolysaccharidosis II – Life with Disease Nephrotic syndrome Marfan’s syndrome Acute respiratory distress syndrome Encephalitis autoimmune – Basic Information KBG syndrome – Basic Information Chronic granulomatous disease – Treatment Short-bowel syndrome – Diagnostics Ewing’s sarcoma metastatic – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Artemisia Vulgaris (312) Cetirizine Sufentanil Letetresgene Autoleucel Dordaviprone Sorafenib Gen1047 Valproic Acid Estradiol Magnesium Stearate Tafasitamab Pacritinib Ranitidine Ofloxacin Hydrochloride Clavulanic Acid Tas3351 Litifilimab Efzofitimod Ponatinib Eplontersen More therapies…

    Learn about Your Condition

    Rectal cancer recurrent Lymphangiosarcoma Embolism Haemodialysis Metastatic glioma Pneumococcal infection Nephroblastoma Neuromyopathy Pulmonary alveolar haemorrhage Meniscus operation Stomatitis Leiomyosarcoma metastatic Meniere's disease Pancreatitis acute Systemic infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • 68Ga-FAPI-46 PET-CT for Initial Staging of Gastric Cancer in Patients Eligible for Curative Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    • Germanium (68Ge) Chloride
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • [18F]CPFPX PET in Patients With Drug-Resistant Epilepsy and Healthy Subjects

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • [18F]CPFPX
    France

  • AZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • AZD0120
    • Bortezomib
    • Carfilzomib
    France Germany Italy Norway Poland Spain

  • Benzydamine Hydrochloride Lozenges for Non-Streptococcal Pharyngotonsillitis in Children Aged 6 to 11 Years

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Tonsillitis
    Investigated Drugs:
    • BENZYDAMINE HYDROCHLORIDE
    Italy

  • A study to evaluate the effects of rifaximin in patients with opioid use disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Substance use disorder
    Investigated Drugs:
    • Rifaximin
    Italy

  • A study of Cesnicabtagene autoleucel compared to a drug combination for patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • AUTOLOGOUS GENETICALLY MODIFIED T LYMPHOCYTES TRANSDUCED WITH LENTIVIRUS EXPRESSING CAR PROTEIN DIRECTED AGAINST BCMA
    • Elotuzumab
    • Bortezomib
    The Netherlands
Previous Page
1 … 714 715 716 717 718 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!